- Home
- SRXH vs BCAB Comparison
SRXH vs BCAB Comparison
Compare SRXH & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRXH
- BCAB
- Stock Information
- Founded
- SRXH 2013
- BCAB 2007
- Country
- SRXH Canada
- BCAB United States
- Employees
- SRXH N/A
- BCAB N/A
- Industry
- SRXH
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- SRXH
- BCAB Health Care
- Exchange
- SRXH NYSE
- BCAB Nasdaq
- Market Cap
- SRXH 27.7M
- BCAB 22.3M
- IPO Year
- SRXH N/A
- BCAB 2020
- Fundamental
- Price
- SRXH $0.60
- BCAB $0.51
- Analyst Decision
- SRXH
- BCAB Buy
- Analyst Count
- SRXH 0
- BCAB 2
- Target Price
- SRXH N/A
- BCAB $1.00
- AVG Volume (30 Days)
- SRXH 7.1M
- BCAB 461.6K
- Earning Date
- SRXH 05-15-2025
- BCAB 05-06-2025
- Dividend Yield
- SRXH N/A
- BCAB N/A
- EPS Growth
- SRXH N/A
- BCAB N/A
- EPS
- SRXH N/A
- BCAB N/A
- Revenue
- SRXH $119,421,918.00
- BCAB $11,000,000.00
- Revenue This Year
- SRXH $26.28
- BCAB N/A
- Revenue Next Year
- SRXH $25.00
- BCAB N/A
- P/E Ratio
- SRXH N/A
- BCAB N/A
- Revenue Growth
- SRXH 26.27
- BCAB N/A
- 52 Week Low
- SRXH $0.47
- BCAB $0.24
- 52 Week High
- SRXH $6.80
- BCAB $2.53
- Technical
- Relative Strength Index (RSI)
- SRXH N/A
- BCAB 65.32
- Support Level
- SRXH N/A
- BCAB $0.39
- Resistance Level
- SRXH N/A
- BCAB $0.42
- Average True Range (ATR)
- SRXH 0.00
- BCAB 0.05
- MACD
- SRXH 0.00
- BCAB 0.00
- Stochastic Oscillator
- SRXH 0.00
- BCAB 96.73
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.